Rosuvastatin reigns supreme for hypercholesterolaemia
- PDF / 141,887 Bytes
- 1 Pages / 623.591 x 841.847 pts Page_size
- 48 Downloads / 213 Views
Ato
Pra*
Sim*
16.93 20.81 19.48
16.98 20.01 17.84
14.04 16.96 15.90
* generic
A cost-effectiveness acceptability curve demonstrated that rosuvastatin was the most cost-effective statin across a wide range of willingness-to-pay values per unit of clinical effect. * This study was funded by AstraZeneca. Costa-Scharplatz M, et al. Cost-effectiveness of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health care perspective. Value in Health 10: A221 (plus oral presentation) abstr. CV2, No. 6, Nov-Dec 801084905 2007
1173-5503/10/0540-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
PharmacoEconomics & Outcomes News 3 Nov 2007 No. 540
1
Data Loading...
